{"query": "what drugs may treat conditions related to Ehlers-Danlos syndrome, hypermobility type?", "results": {"cyclosporine": ["cyclosporine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclosporine-[treats or applied or studied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclosporine-[causes increased activity of]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "cyclosporine-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "citalopram": ["citalopram-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lidocaine": ["lidocaine-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sodium chloride": ["sodium chloride-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Adrenal Cortex Hormones": ["Adrenal Cortex Hormones-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dexamethasone": ["dexamethasone-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "paracetamol": ["paracetamol-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "melatonin": ["melatonin-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ONABOTULINUMTOXINA": ["ONABOTULINUMTOXINA-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "propranolol": ["propranolol-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "aspirin": ["aspirin-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pregabalin": ["pregabalin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "fentanyl": ["fentanyl-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bupivacaine": ["bupivacaine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-ptosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-Umbilical hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "colecalciferol": ["colecalciferol-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[in clinical trials for]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "fluoxetine": ["fluoxetine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "duloxetine": ["duloxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Botulinum Toxins": ["Botulinum Toxins-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ibuprofen": ["ibuprofen-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[applied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cortisol": ["cortisol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[affects]-TGFB1-[physically interacts with]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "gabapentin": ["gabapentin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[applied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "diclofenac": ["diclofenac-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[applied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "caffeine": ["caffeine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "naloxone": ["naloxone-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "magnesium sulfate": ["magnesium sulfate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Fish Oils": ["Fish Oils-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Opioids": ["Opioids-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "venlafaxine": ["venlafaxine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "simvastatin": ["simvastatin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "simvastatin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "simvastatin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "simvastatin-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ketorolac": ["ketorolac-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "midazolam": ["midazolam-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Anti-Inflammatory Agents, Non-Steroidal": ["Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "analgesic": ["analgesic-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "propofol": ["propofol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ondansetron": ["ondansetron-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[in clinical trials for]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "celecoxib": ["celecoxib-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nifedipine": ["nifedipine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cyclobenzaprine": ["cyclobenzaprine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclobenzaprine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclobenzaprine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclobenzaprine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "methylprednisolone": ["methylprednisolone-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "methotrexate": ["methotrexate-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "clonidine": ["clonidine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "indomethacin": ["indomethacin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "methadone": ["methadone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[in clinical trials for]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "buprenorphine": ["buprenorphine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "risperidone": ["risperidone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "testosterone propionate": ["testosterone propionate-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "testosterone propionate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "testosterone propionate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "testosterone propionate-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "morphine": ["morphine-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "haloperidol": ["haloperidol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[applied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Basis": ["Basis-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cannabidiol": ["cannabidiol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Calcium Channel Blockers": ["Calcium Channel Blockers-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Metric (substance)": ["Metric (substance)-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "immunological adjuvant": ["immunological adjuvant-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "capsaicin": ["capsaicin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "codeine": ["codeine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "codeine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "codeine-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "codeine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "naproxen": ["naproxen-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "olanzapine": ["olanzapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "5-hydroxytryptamine": ["5-hydroxytryptamine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lacosamide": ["lacosamide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lacosamide-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lacosamide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lacosamide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ubidecarenone": ["ubidecarenone-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prazosin": ["prazosin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prazosin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prazosin-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prazosin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "promethazine": ["promethazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "quetiapine": ["quetiapine-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "esomeprazole": ["esomeprazole-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "oxygen": ["oxygen-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-DEXPROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-hydrated silica-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-PROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-proteoglycan-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "atenolol": ["atenolol-[applied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atenolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atenolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atenolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "metformin": ["metformin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metformin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metformin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metformin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "memantine": ["memantine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "amlodipine": ["amlodipine-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amlodipine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amlodipine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "L-ascorbic acid": ["L-ascorbic acid-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "oxytocin": ["oxytocin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxytocin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxytocin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "(-)-adrenaline": ["(-)-adrenaline-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[in clinical trials for]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "amitriptyline": ["amitriptyline-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Adrenergic beta-Antagonists": ["Adrenergic beta-Antagonists-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[treats or applied or studied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "atorvastatin": ["atorvastatin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atorvastatin-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atorvastatin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "paroxetine": ["paroxetine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tramadol": ["tramadol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "L-carnitine": ["L-carnitine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-carnitine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-carnitine-[in clinical trials for]-Muscle weakness-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-carnitine-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "botulinum toxin type A": ["botulinum toxin type A-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ergocalciferol": ["ergocalciferol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sirolimus": ["sirolimus-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sirolimus-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sirolimus-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lorazepam": ["lorazepam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "WATER": ["WATER-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[in clinical trials for]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ropivacaine": ["ropivacaine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ropivacaine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ropivacaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "TONICS": ["TONICS-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TONICS-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tranexamic acid": ["tranexamic acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[applied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[in clinical trials for]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "metoclopramide": ["metoclopramide-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "naltrexone": ["naltrexone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Serotonin Uptake Inhibitors": ["Serotonin Uptake Inhibitors-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ketamine": ["ketamine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "trazodone": ["trazodone-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Vitamin E": ["Vitamin E-[applied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "BENZODIAZEPINE": ["BENZODIAZEPINE-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "imipramine": ["imipramine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "quinine": ["quinine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ethanol": ["ethanol-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Marihuana": ["Marihuana-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dexmedetomidine": ["dexmedetomidine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "diltiazem": ["diltiazem-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diltiazem-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diltiazem-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "colchicine": ["colchicine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colchicine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colchicine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dopamine": ["dopamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dopamine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dopamine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dopamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "diphenhydramine": ["diphenhydramine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "valproic acid": ["valproic acid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "triamcinolone": ["triamcinolone-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[affects]-TGFB1-[physically interacts with]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "bupropion": ["bupropion-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prednisone": ["prednisone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisone-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lansoprazole": ["lansoprazole-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "methylphenidate": ["methylphenidate-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "metoprolol": ["metoprolol-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[applied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "riboflavin": ["riboflavin-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[treats or applied or studied to treat]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[in clinical trials for]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lamotrigine": ["lamotrigine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "PROPRANOLOL HYDROCHLORIDE": ["PROPRANOLOL HYDROCHLORIDE-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PROPRANOLOL HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PROPRANOLOL HYDROCHLORIDE-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tretinoin": ["tretinoin-[treats or applied or studied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tretinoin-[in clinical trials for]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tretinoin-[treats or applied or studied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "timolol": ["timolol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "timolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "timolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "mitomycin C": ["mitomycin C-[treats or applied or studied to treat]-High myopia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mitomycin C-[in clinical trials for]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "clomipramine": ["clomipramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "hydroxychloroquine": ["hydroxychloroquine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxychloroquine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxychloroquine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxychloroquine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "mirtazapine": ["mirtazapine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "alprazolam": ["alprazolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dehydroepiandrosterone": ["dehydroepiandrosterone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "BUPRENORPHINE": ["BUPRENORPHINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPRENORPHINE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPRENORPHINE-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sertraline": ["sertraline-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "progesterone": ["progesterone-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "progesterone-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "progesterone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "hydrocodone": ["hydrocodone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydrocodone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydrocodone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "buspirone": ["buspirone-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "desvenlafaxine": ["desvenlafaxine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desvenlafaxine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desvenlafaxine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desvenlafaxine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "folic acid": ["folic acid-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[in clinical trials for]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[applied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "meloxicam": ["meloxicam-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "verapamil": ["verapamil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nortriptyline": ["nortriptyline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prochlorperazine": ["prochlorperazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dextromethorphan": ["dextromethorphan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dextromethorphan-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "oxymetazoline": ["oxymetazoline-[in clinical trials for]-ptosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxymetazoline-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "topiramate": ["topiramate-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "citric acid": ["citric acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citric acid-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citric acid-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citric acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "temazepam": ["temazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "temazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "temazepam-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "misoprostol (methyl ester)": ["misoprostol (methyl ester)-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "misoprostol (methyl ester)-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "misoprostol (methyl ester)-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "acetylcysteine": ["acetylcysteine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Oils, Volatile": ["Oils, Volatile-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Oils, Volatile-[preventative for condition]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Oils, Volatile-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Oils, Volatile-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "oxycodone": ["oxycodone-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Vitamin supplementation": ["Vitamin supplementation-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin supplementation-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin supplementation-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin supplementation-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "acide gras essentiel": ["acide gras essentiel-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acide gras essentiel-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acide gras essentiel-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acide gras essentiel-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cyclooxygenase 2 inhibitor": ["cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Antipsychotic Agents": ["Antipsychotic Agents-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antipsychotic Agents-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antipsychotic Agents-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antipsychotic Agents-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Hypnotics": ["Hypnotics-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hypnotics-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hypnotics-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hypnotics-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "\u03949-tetrahydrocannabinol": ["\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cannabinol": ["cannabinol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabinol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabinol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabinol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Tricyclic Antidepressive Agents": ["Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Olives - dietary": ["Olives - dietary-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Olives - dietary-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Olives - dietary-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pramipexole": ["pramipexole-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pramipexole-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pramipexole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nitroglycerin": ["nitroglycerin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nitroglycerin-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nitroglycerin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "digoxin": ["digoxin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "digoxin-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "digoxin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "hyaluronan": ["hyaluronan-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[treats or applied or studied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ketoprofen": ["ketoprofen-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "omega-3 fatty acid": ["omega-3 fatty acid-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "estrogen": ["estrogen-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estrogen-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estrogen-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estrogen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "curcumin": ["curcumin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "phenytoin": ["phenytoin-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "rocuronium": ["rocuronium-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rocuronium-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rocuronium-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "succinylcholine": ["succinylcholine-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "succinylcholine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nicardipine": ["nicardipine-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicardipine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicardipine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "potassium chloride": ["potassium chloride-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "potassium chloride-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "potassium chloride-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "potassium chloride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "thioridazine": ["thioridazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thioridazine-[regulates]-TMEM43-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "thioridazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "magnesium hydroxide": ["magnesium hydroxide-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[applied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "aripiprazole": ["aripiprazole-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "thioctic acid": ["thioctic acid-[has part]-SULFUR, PRECIPITATED-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-hydrogen(.)-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-hydrogen(.)-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-SULFUR, PRECIPITATED-[part of]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-water-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-water-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-water-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "salbutamol": ["salbutamol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "salbutamol-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nadolol": ["nadolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nadolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dexamfetamine": ["dexamfetamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamfetamine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "immunoglobulins, intravenous": ["immunoglobulins, intravenous-[treats or applied or studied to treat]-Muscle weakness-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunoglobulins, intravenous-[treats or applied or studied to treat]-dysautonomia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "diazepam": ["diazepam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nicotinic acid": ["nicotinic acid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicotinic acid-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicotinic acid-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "clonazepam": ["clonazepam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "estradiol valerate": ["estradiol valerate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estradiol valerate-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estradiol valerate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Biological Products": ["Biological Products-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Biological Products-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "acebutolol": ["acebutolol-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acebutolol-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acebutolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acebutolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "zolpidem": ["zolpidem-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zolpidem-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zolpidem-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zolpidem-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "infliximab": ["infliximab-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "infliximab-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "infliximab-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "human leukocyte interferon": ["human leukocyte interferon-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "human leukocyte interferon-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "human leukocyte interferon-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "REBOXETINE": ["REBOXETINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "REBOXETINE-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "REBOXETINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Duration": ["Duration-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Duration-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Duration-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "diflunisal": ["diflunisal-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sildenafil": ["sildenafil-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sildenafil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sildenafil-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "hydroxyzine": ["hydroxyzine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxyzine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxyzine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "famotidine": ["famotidine-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bisacodyl": ["bisacodyl-[regulates]-B4GALT7-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "steroid": ["steroid-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "steroid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "steroid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "opioid analgesic": ["opioid analgesic-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opioid analgesic-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opioid analgesic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "doxepin": ["doxepin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "minocycline": ["minocycline-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "minocycline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "minocycline-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "minocycline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Hallucinogens": ["Hallucinogens-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hallucinogens-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hallucinogens-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "carbamazepine": ["carbamazepine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "carbamazepine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "carbamazepine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "carbamazepine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nabiximols": ["nabiximols-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nabiximols-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nabiximols-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "levodopa": ["levodopa-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levodopa-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levodopa-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Psychotropic Drugs": ["Psychotropic Drugs-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Psychotropic Drugs-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Psychotropic Drugs-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "octreotide": ["octreotide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "octreotide-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "octreotide-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "BUPIVACAINE HYDROCHLORIDE": ["BUPIVACAINE HYDROCHLORIDE-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPIVACAINE HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPIVACAINE HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "acetazolamide": ["acetazolamide-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetazolamide-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetazolamide-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetazolamide-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Gotu kola": ["Gotu kola-[applied to treat]-venous insufficiency-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Gotu kola-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Gotu kola-[applied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dimethyl sulfoxide": ["dimethyl sulfoxide-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Tumeric": ["Tumeric-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tumeric-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tumeric-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Lavandula": ["Lavandula-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lavandula-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lavandula-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lithium carbonate": ["lithium carbonate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "esflurbiprofen": ["esflurbiprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esflurbiprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esflurbiprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esflurbiprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tolmetin": ["tolmetin-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "piroxicam": ["piroxicam-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "flurbiprofen": ["flurbiprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurbiprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurbiprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurbiprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "meclofenamic acid": ["meclofenamic acid-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "aceclofenac": ["aceclofenac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "felbinac": ["felbinac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "felbinac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "felbinac-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "felbinac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "etofenamate": ["etofenamate-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etofenamate-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etofenamate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etofenamate-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "(+)-menthol": ["(+)-menthol-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(+)-menthol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(+)-menthol-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "quercetin": ["quercetin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quercetin-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quercetin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quercetin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prednisolone": ["prednisolone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisolone-[treats or applied or studied to treat]-Muscle weakness-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisolone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisolone-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "statin": ["statin-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "phenylbutazone": ["phenylbutazone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenylbutazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenylbutazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nimesulide": ["nimesulide-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nimesulide-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nimesulide-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "active ingredient": ["active ingredient-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "active ingredient-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "active ingredient-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "New medications": ["New medications-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "New medications-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "New medications-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "feprazone": ["feprazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "feprazone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "feprazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "CHEMBL.COMPOUND:CHEMBL5314358": ["CHEMBL.COMPOUND:CHEMBL5314358-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CHEMBL.COMPOUND:CHEMBL5314358-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CHEMBL.COMPOUND:CHEMBL5314358-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "reserpine": ["reserpine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "reserpine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "reserpine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ethinylestradiol": ["ethinylestradiol-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethinylestradiol-[applied to treat]-Menometrorrhagia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethinylestradiol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethinylestradiol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "piracetam": ["piracetam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piracetam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piracetam-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "thiethylperazine": ["thiethylperazine-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thiethylperazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thiethylperazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thiethylperazine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dexketoprofen": ["dexketoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexketoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexketoprofen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "desipramine": ["desipramine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "PSILOCYBINE": ["PSILOCYBINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "perphenazine": ["perphenazine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "levetiracetam": ["levetiracetam-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levetiracetam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levetiracetam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levetiracetam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "perazine": ["perazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "clozapine": ["clozapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clozapine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clozapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clozapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "phenobarbital": ["phenobarbital-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenobarbital-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenobarbital-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenobarbital-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "theophylline": ["theophylline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "chlorpromazine": ["chlorpromazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorpromazine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorpromazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorpromazine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Prescribed medications": ["Prescribed medications-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Prescribed medications-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Prescribed medications-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sodium bicarbonate": ["sodium bicarbonate-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium bicarbonate-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium bicarbonate-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "atracurium": ["atracurium-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atracurium-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "isovaleryl-CoA": ["isovaleryl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "armodafinil": ["armodafinil-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "armodafinil-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "armodafinil-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "METHYLPHENIDATE HYDROCHLORIDE": ["METHYLPHENIDATE HYDROCHLORIDE-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "METHYLPHENIDATE HYDROCHLORIDE-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "METHYLPHENIDATE HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "modafinil": ["modafinil-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "polyvinyl alcohol": ["polyvinyl alcohol-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "polyvinyl alcohol-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "acetyl-L-carnitine": ["acetyl-L-carnitine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetyl-L-carnitine-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetyl-L-carnitine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "amantadine": ["amantadine-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amantadine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amantadine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Interferons": ["Interferons-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Interferons-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ribavirin": ["ribavirin-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ribavirin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ribavirin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Interferon-alpha": ["Interferon-alpha-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Interferon-alpha-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Psychostimulant (substance)": ["Psychostimulant (substance)-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Psychostimulant (substance)-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "afatinib": ["afatinib-[regulates]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "tapentadol": ["tapentadol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tapentadol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tapentadol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "FEPIXNEBART": ["FEPIXNEBART-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "FEPIXNEBART-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ATB-346": ["ATB-346-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ATB-346-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "FULRANUMAB": ["FULRANUMAB-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "FULRANUMAB-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ebaresdax": ["ebaresdax-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ebaresdax-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "etoricoxib": ["etoricoxib-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etoricoxib-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etoricoxib-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "HYDROCODONE BITARTRATE": ["HYDROCODONE BITARTRATE-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "HYDROCODONE BITARTRATE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "TANEZUMAB": ["TANEZUMAB-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TANEZUMAB-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Cyclooxygenase Inhibitors": ["Cyclooxygenase Inhibitors-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Cyclooxygenase Inhibitors-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Analgesics, Non-Narcotic": ["Analgesics, Non-Narcotic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Analgesics, Non-Narcotic-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "anashca": ["anashca-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "anashca-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "milnacipran": ["milnacipran-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "milnacipran-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "milnacipran-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "milnacipran-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Adjuvant Analgesic": ["Adjuvant Analgesic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adjuvant Analgesic-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Atypical antipsychotic": ["Atypical antipsychotic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Atypical antipsychotic-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "NMDA receptor antagonist": ["NMDA receptor antagonist-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "NMDA receptor antagonist-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Medical Marijuana": ["Medical Marijuana-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Medical Marijuana-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "hydromorphone": ["hydromorphone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydromorphone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydromorphone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lubiprostone": ["lubiprostone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lubiprostone-[applied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lubiprostone-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lubiprostone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Narcotic Antagonists": ["Narcotic Antagonists-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Narcotic Antagonists-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "2-phenyl-benzopyrans": ["2-phenyl-benzopyrans-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "2-phenyl-benzopyrans-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "capsicum": ["capsicum-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsicum-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "LIDOCAINE HYDROCHLORIDE": ["LIDOCAINE HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "LIDOCAINE HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "N-palmitoylethanolamine": ["N-palmitoylethanolamine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "N-palmitoylethanolamine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "metamizole": ["metamizole-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metamizole-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metamizole-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Opiates": ["Opiates-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opiates-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Narcotics": ["Narcotics-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Narcotics-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Drug Combinations": ["Drug Combinations-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Drug Combinations-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "mexiletine": ["mexiletine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mexiletine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mexiletine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mexiletine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "local anaesthetic": ["local anaesthetic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "local anaesthetic-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Sodium Channel Blockers": ["Sodium Channel Blockers-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Sodium Channel Blockers-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "AZD2066": ["AZD2066-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "AZD2066-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "(2E)-Dodecenoyl-CoA": ["(2E)-Dodecenoyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "ocriplasmin": ["ocriplasmin-[affects]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "ocriplasmin-[affects]-COL6A5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "ocriplasmin-[affects]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "iron": ["iron-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dabrafenib": ["dabrafenib-[regulates]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "METOPROLOL FUMARATE": ["METOPROLOL FUMARATE-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tacrine": ["tacrine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tacrine-[preventative for condition]-Joint dislocation-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tacrine-[treats or applied or studied to treat]-Joint dislocation-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Onions": ["Onions-[applied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Onions-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ROSE HIPS": ["ROSE HIPS-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ROSE HIPS-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ROSE HIPS-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bevacizumab": ["bevacizumab-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bevacizumab-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Cod Liver Oil": ["Cod Liver Oil-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Cod Liver Oil-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "creatine": ["creatine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "creatine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "D-glucosamine": ["D-glucosamine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nicotinamide": ["nicotinamide-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicotinamide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Soybeans": ["Soybeans-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Soybeans-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "retinol": ["retinol-[preventative for condition]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "retinol-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "retinol-[treats or applied or studied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Ginger (dietary)": ["Ginger (dietary)-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Ginger (dietary)-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Urtica": ["Urtica-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Urtica-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "black cohosh extract": ["black cohosh extract-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "black cohosh extract-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "choline": ["choline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "choline-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "choline-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "rofecoxib": ["rofecoxib-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "magnesium salicylate": ["magnesium salicylate-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium salicylate-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium salicylate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium salicylate-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "choline dehydrocholate": ["choline dehydrocholate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "choline dehydrocholate-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "LIGUSTRAZINE": ["LIGUSTRAZINE-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "LIGUSTRAZINE-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "1,200 mg": ["1,200 mg-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "1,200 mg-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "3-rhamnosyl-glucosyl quercetin": ["3-rhamnosyl-glucosyl quercetin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "3-rhamnosyl-glucosyl quercetin-[treats or applied or studied to treat]-venous insufficiency-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "vancomycin": ["vancomycin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vancomycin-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ROPIVACAINE HYDROCHLORIDE": ["ROPIVACAINE HYDROCHLORIDE-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ROPIVACAINE HYDROCHLORIDE-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "rebamipide": ["rebamipide-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rebamipide-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "CHEMBL.COMPOUND:CHEMBL5314366": ["CHEMBL.COMPOUND:CHEMBL5314366-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CHEMBL.COMPOUND:CHEMBL5314366-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "polysaccharide": ["polysaccharide-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Diphosphonates": ["Diphosphonates-[treats or applied or studied to treat]-lytic metastatic bone lesion-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Diphosphonates-[preventative for condition]-lytic metastatic bone lesion-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Diphosphonates-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "glucocorticoid": ["glucocorticoid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "glucocorticoid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "leptin": ["leptin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "leptin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "resveratrol": ["resveratrol-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "resveratrol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "resveratrol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "polyphenol": ["polyphenol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "polyphenol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Proton Pump Inhibitors": ["Proton Pump Inhibitors-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Proton Pump Inhibitors-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Proton Pump Inhibitors-[preventative for condition]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "methionine": ["methionine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methionine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "glucose": ["glucose-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "glucose-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Clodronate": ["Clodronate-[treats or applied or studied to treat]-lytic metastatic bone lesion-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Clodronate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ORALIT": ["ORALIT-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ORALIT-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prostaglandin": ["prostaglandin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prostaglandin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "S-adenosylmethionine": ["S-adenosylmethionine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "S-adenosylmethionine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "S-adenosylmethionine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Anticoagulants": ["Anticoagulants-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anticoagulants-[treats or applied or studied to treat]-Arterial dissection-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "myo-inositol": ["myo-inositol-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "myo-inositol-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "myo-inositol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Ginkgo <Ginkgoaceae>": ["Ginkgo <Ginkgoaceae>-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Ginkgo <Ginkgoaceae>-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ST. JOHN'S WORT": ["ST. JOHN'S WORT-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ST. JOHN'S WORT-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cinnarizine": ["cinnarizine-[treats]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cinnarizine-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cinnarizine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cinnarizine-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dimenhydrinate": ["dimenhydrinate-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[treats]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "DIPHENHYDRAMINE HYDROCHLORIDE": ["DIPHENHYDRAMINE HYDROCHLORIDE-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "DIPHENHYDRAMINE HYDROCHLORIDE-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "flunarizine": ["flunarizine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "chlormezanone": ["chlormezanone-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlormezanone-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlormezanone-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ramelteon": ["ramelteon-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ramelteon-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "CLOFEZONE": ["CLOFEZONE-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CLOFEZONE-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "benzydamine": ["benzydamine-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "benzydamine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "OXYPHENBUTAZONE": ["OXYPHENBUTAZONE-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "OXYPHENBUTAZONE-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "fentiazac": ["fentiazac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentiazac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "IDROCILAMIDE": ["IDROCILAMIDE-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "IDROCILAMIDE-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "piketoprofen": ["piketoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piketoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "mofebutazone": ["mofebutazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mofebutazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bendazac": ["bendazac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bendazac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "loxoprofen": ["loxoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "loxoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tolazoline": ["tolazoline-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolazoline-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "suxibuzone": ["suxibuzone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "suxibuzone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nifenazone": ["nifenazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifenazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "zucapsaicin": ["zucapsaicin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zucapsaicin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "hydroxocobalamin": ["hydroxocobalamin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxocobalamin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxocobalamin-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxocobalamin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "niflumic acid": ["niflumic acid-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "niflumic acid-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bufexamac": ["bufexamac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bufexamac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tolperisone": ["tolperisone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolperisone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "rosuvastatin": ["rosuvastatin-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rosuvastatin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "fluvoxamine": ["fluvoxamine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluvoxamine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluvoxamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluvoxamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "EPA": ["EPA-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "EPA-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "EPA-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "EPA-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "5-hydroxy-L-tryptophan": ["5-hydroxy-L-tryptophan-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxy-L-tryptophan-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxy-L-tryptophan-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxy-L-tryptophan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "docosahexaenoic acid": ["docosahexaenoic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "docosahexaenoic acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "docosahexaenoic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "docosahexaenoic acid-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "L-tryptophan": ["L-tryptophan-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-tryptophan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-tryptophan-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-tryptophan-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "zinc(0)": ["zinc(0)-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zinc(0)-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zinc(0)-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "trimipramine": ["trimipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trimipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trimipramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trimipramine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "maprotiline": ["maprotiline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "maprotiline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "maprotiline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "maprotiline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "moclobemide": ["moclobemide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "moclobemide-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "moclobemide-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "moclobemide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ethyl loflazepate": ["ethyl loflazepate-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "opipramol": ["opipramol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opipramol-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opipramol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opipramol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "mifepristone": ["mifepristone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mifepristone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mifepristone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Loflazepic acid": ["Loflazepic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Loflazepic acid-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "donepezil": ["donepezil-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "donepezil-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "donepezil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "citrate": ["citrate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citrate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "escitalopram": ["escitalopram-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Plant Preparations": ["Plant Preparations-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Plant Preparations-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "saline": ["saline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "saline-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "co q10": ["co q10-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "co q10-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "DESIPRAMINE HYDROCHLORIDE": ["DESIPRAMINE HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "DESIPRAMINE HYDROCHLORIDE-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pyritinol": ["pyritinol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pyritinol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sulpiride": ["sulpiride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sulpiride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sulpiride-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "oxaflozane": ["oxaflozane-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxaflozane-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxaflozane-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "amisulpride": ["amisulpride-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amisulpride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amisulpride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "oxazepam": ["oxazepam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxazepam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "acamprosate": ["acamprosate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acamprosate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prucalopride": ["prucalopride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prucalopride-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prucalopride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prucalopride-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "zaleplon": ["zaleplon-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zaleplon-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "rivastigmine": ["rivastigmine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rivastigmine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nicergoline": ["nicergoline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicergoline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nitrazepam": ["nitrazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nitrazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "lormetazepam": ["lormetazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lormetazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "amibegron": ["amibegron-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amibegron-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "paliperidone": ["paliperidone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paliperidone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "flupentixol": ["flupentixol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flupentixol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flupentixol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "zuclopenthixol": ["zuclopenthixol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zuclopenthixol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "VITAMIN E": ["VITAMIN E-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "VITAMIN E-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "biperiden": ["biperiden-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "biperiden-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "TRANYLCYPROMINE": ["TRANYLCYPROMINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TRANYLCYPROMINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nelivaptan": ["nelivaptan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nelivaptan-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pimozide": ["pimozide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pimozide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "flurazepam": ["flurazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "(-)-noradrenaline": ["(-)-noradrenaline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-noradrenaline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-noradrenaline-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "levomepromazine": ["levomepromazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levomepromazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "TC-2216": ["TC-2216-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TC-2216-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ziprasidone": ["ziprasidone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ziprasidone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ziprasidone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ziprasidone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pindolol": ["pindolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pindolol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pindolol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "IMIPRAMINE HYDROCHLORIDE": ["IMIPRAMINE HYDROCHLORIDE-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "IMIPRAMINE HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "chloral hydrate": ["chloral hydrate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chloral hydrate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pivagabine": ["pivagabine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pivagabine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ethosuximide": ["ethosuximide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethosuximide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "oxcarbazepine": ["oxcarbazepine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxcarbazepine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sertindole": ["sertindole-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertindole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "DONEPEZIL HYDROCHLORIDE": ["DONEPEZIL HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "DONEPEZIL HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "clobazam": ["clobazam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clobazam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "brotizolam": ["brotizolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "brotizolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bromazepam": ["bromazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bromazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "chlorprothixene": ["chlorprothixene-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorprothixene-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "tiapride": ["tiapride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tiapride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "melperone": ["melperone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melperone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "zopiclone": ["zopiclone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zopiclone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "mianserin": ["mianserin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mianserin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mianserin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "agomelatine": ["agomelatine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "agomelatine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "agomelatine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "agomelatine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "galantamine": ["galantamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "galantamine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bromperidol": ["bromperidol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bromperidol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "SAREDUTANT": ["SAREDUTANT-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "SAREDUTANT-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "vortioxetine": ["vortioxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vortioxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vortioxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vortioxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "fluphenazine": ["fluphenazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluphenazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "fluspirilene": ["fluspirilene-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluspirilene-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "vilazodone": ["vilazodone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vilazodone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vilazodone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vilazodone-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "triazolam": ["triazolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triazolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prothipendyl": ["prothipendyl-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prothipendyl-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pipamperone": ["pipamperone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pipamperone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "benperidol": ["benperidol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "benperidol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "clomethiazole": ["clomethiazole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomethiazole-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Insulin": ["Insulin-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Insulin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "argipressin": ["argipressin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "argipressin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Selective Serotonin Reuptake Inhibitors": ["Selective Serotonin Reuptake Inhibitors-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Selective Serotonin Reuptake Inhibitors-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Selective Serotonin Reuptake Inhibitors-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "bromocriptine": ["bromocriptine-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bromocriptine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "nimodipine": ["nimodipine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nimodipine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "MDMA": ["MDMA-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "MDMA-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "4,4'-Diamino-2,2'-stilbenedisulfonic acid": ["4,4'-Diamino-2,2'-stilbenedisulfonic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "4,4'-Diamino-2,2'-stilbenedisulfonic acid-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Lysergide": ["Lysergide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lysergide-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lysergide-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "isoprenaline": ["isoprenaline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "isoprenaline-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Serotonin Agonists": ["Serotonin Agonists-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Agonists-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Antiepileptic Agents": ["Antiepileptic Agents-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiepileptic Agents-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiepileptic Agents-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Contraceptives, Oral": ["Contraceptives, Oral-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Contraceptives, Oral-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Prescription Drugs": ["Prescription Drugs-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Prescription Drugs-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "growth hormone": ["growth hormone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "growth hormone-[treats or applied or studied to treat]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "adenosine 5'-monophosphate": ["adenosine 5'-monophosphate-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "adenosine 5'-monophosphate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "adenosine 5'-monophosphate-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "flumazenil": ["flumazenil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flumazenil-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "arginine": ["arginine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "arginine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "arginine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Excitatory Amino Acid Antagonists": ["Excitatory Amino Acid Antagonists-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Excitatory Amino Acid Antagonists-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "atropine": ["atropine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atropine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atropine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "loxapine": ["loxapine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "loxapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "butorphanol": ["butorphanol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "butorphanol-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "butorphanol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "OLANZAPINE PAMOATE": ["OLANZAPINE PAMOATE-[applied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "OLANZAPINE PAMOATE-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "domperidone": ["domperidone-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "domperidone-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "domperidone-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "domperidone-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Antiemetics": ["Antiemetics-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiemetics-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiemetics-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "macrogol": ["macrogol-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[applied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "magnesium carbonate": ["magnesium carbonate-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "TEGASEROD": ["TEGASEROD-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TEGASEROD-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TEGASEROD-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "mosapride": ["mosapride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mosapride-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "propylene glycol": ["propylene glycol-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propylene glycol-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cisapride": ["cisapride-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cisapride-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cisapride-[preventative for condition]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cisapride-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prokinetic agent": ["prokinetic agent-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prokinetic agent-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Sanguinaria canadensis": ["Sanguinaria canadensis-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Sanguinaria canadensis-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "RASEGLURANT": ["RASEGLURANT-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "RASEGLURANT-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "progestin": ["progestin-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "progestin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Angiotensin-Converting Enzyme Inhibitors": ["Angiotensin-Converting Enzyme Inhibitors-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Angiotensin-Converting Enzyme Inhibitors-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Angiotensin-Converting Enzyme Inhibitors-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pethidine": ["pethidine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pethidine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "cefazolin": ["cefazolin-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cefazolin-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "alfacalcidol": ["alfacalcidol-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alfacalcidol-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "dactinomycin": ["dactinomycin-[regulates]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "dactinomycin-[affects]-HTT-[physically interacts with]-TMEM43-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "benzoic acid": ["benzoic acid-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "1,2-DIBROMOETHANE": ["1,2-DIBROMOETHANE-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "oxymorphone": ["oxymorphone-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxymorphone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxymorphone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "(1S,2R)-naphthalene 1,2-oxide": ["(1S,2R)-naphthalene 1,2-oxide-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "cyclophosphamide": ["cyclophosphamide-[affects]-glutathione-[physically interacts with]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "CHARCOAL, ACTIVATED": ["CHARCOAL, ACTIVATED-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-PROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-DEXPROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-proteoglycan-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "nitrogen": ["nitrogen-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-proteoglycan-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-DEXPROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-PROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "glycosaminoglycan": ["glycosaminoglycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-cartilage tissue-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "acryloyl-CoA": ["acryloyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "2,2-Dichloroacetaldehyde": ["2,2-Dichloroacetaldehyde-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "sulfates": ["sulfates-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "sulfated glycosaminoglycan": ["sulfated glycosaminoglycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "mucopolysaccharide": ["mucopolysaccharide-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "glycan": ["glycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "organic sulfate": ["organic sulfate-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "carbohydrate sulfate": ["carbohydrate sulfate-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "collagenase": ["collagenase-[affects]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "collagenase-[affects]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "collagenase-[affects]-COL6A5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "sulfur": ["sulfur-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "keratan sulfate": ["keratan sulfate-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "sulfonyl group": ["sulfonyl group-[has active ingredient]-glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-methylsulfonylmethane / molybdenum-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-camphor / menthol / methyl salicylate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-RXCUI:1007537-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-GLUCOSAMINE/METHYLSULFONYLMETHANE-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-chondroitin sulfates / glucosamine / methylsulfonylmethane / tocopherol-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "sufinpyrazone": ["sufinpyrazone-[regulates]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "idarubicin": ["idarubicin-[regulates]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "aldehydo-D-glucosamine": ["aldehydo-D-glucosamine-[has active ingredient]-chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-chondroitin sulfates / glucosamine / methylsulfonylmethane / tocopherol-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-GLUCOSAMINE/METHYLSULFONYLMETHANE-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-RXCUI:1007537-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "tienilic acid": ["tienilic acid-[has part]-hydrogen(.)-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-SULFUR, PRECIPITATED-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-water-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-SULFUR, PRECIPITATED-[part of]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-hydrogen(.)-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-water-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-water-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "silicon molecular entity": ["silicon molecular entity-[is input of]-response to silicon dioxide-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[is input of]-silicate transmembrane transporter activity-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[is input of]-silicic acid import across plasma membrane-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[part of]-hydrated silica-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "(2E)-Octenoyl-CoA": ["(2E)-Octenoyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "oxide": ["oxide-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxide-[is input of]-response to silicon dioxide-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxide-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxide-[part of]-hydrated silica-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene": ["(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "crizotinib": ["crizotinib-[regulates]-TNXB-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "naphthalene 1,2-oxide": ["naphthalene 1,2-oxide-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "daunorubicin": ["daunorubicin-[regulates]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "METOPROLOL SUCCINATE": ["METOPROLOL SUCCINATE-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "S-(2,2-Dichloro-1-hydroxy)ethyl glutathione": ["S-(2,2-Dichloro-1-hydroxy)ethyl glutathione-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "GINSENG, ASIAN": ["GINSENG, ASIAN-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "docetaxel": ["docetaxel-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ANAMORELIN HYDROCHLORIDE": ["ANAMORELIN HYDROCHLORIDE-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "erythropoietin": ["erythropoietin-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "erythropoietin-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "CLAZAKIZUMAB": ["CLAZAKIZUMAB-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "disulfiram": ["disulfiram-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "pemoline": ["pemoline-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "juzentaihoto": ["juzentaihoto-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "eculizumab": ["eculizumab-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Antirheumatic Drugs, Disease-Modifying": ["Antirheumatic Drugs, Disease-Modifying-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "glatiramer acetate": ["glatiramer acetate-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "Immunomodulators": ["Immunomodulators-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "monoclonal antibody AN100226": ["monoclonal antibody AN100226-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "rituximab": ["rituximab-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "(2E)-Tetradecenoyl-CoA": ["(2E)-Tetradecenoyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"], "\u03c9-conotoxin MVIIA": ["\u03c9-conotoxin MVIIA-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03c9-conotoxin MVIIA-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "sufentanil": ["sufentanil-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "PF-04457845": ["PF-04457845-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "TRAMADOL HYDROCHLORIDE": ["TRAMADOL HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "prilocaine": ["prilocaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "HYDROMORPHONE HYDROCHLORIDE": ["HYDROMORPHONE HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "KETOTIFEN FUMARATE": ["KETOTIFEN FUMARATE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"], "ester": ["ester-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "sulfuric ester": ["sulfuric ester-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "sulfuric acid derivative": ["sulfuric acid derivative-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "aminoglycan": ["aminoglycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "polysaccharide derivative": ["polysaccharide derivative-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "sulfur oxoacid derivative": ["sulfur oxoacid derivative-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"], "(S)-lipoic acid": ["(S)-lipoic acid-[has part]-water-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-SULFUR, PRECIPITATED-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-water-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-hydrogen(.)-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-water-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-SULFUR, PRECIPITATED-[part of]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-hydrogen(.)-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}}
